Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma

Benzer Materyaller

• Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors
  Yazar:: Ming-Ju Tsai, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-11-01)
• Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors
  Yazar:: Tsai, Ming-Ju, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy
  Yazar:: Yang, Chih-Jen, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
  Yazar:: Yang, Chih-Jen, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• The Factors Predicting Concordant Epidermal Growth Factor Receptor (EGFR) Mutation Detected in Liquid/Tissue Biopsy and the Related Clinical Outcomes in Patients of Advanced Lung Adenocarcinoma with EGFR Mutations
  Yazar:: Kuo, Chia-Yu, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)